Abiopharma

New Form 8-K - Candel Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145405 Size: 338 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits